Chuanrui Xu

7PUBLICATIONS
16CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityMedical bacteriologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 23, 2026
Design, Synthesis, and Biological Evaluation of Novel, Fluorinated Camptothecin Derivatives as Potential Topoisomerase I Inhibitors.

|Oct 24, 2025
SIRT6 promotes intrahepatic cholangiocarcinoma development by reprogramming glutamine metabolism via enhanced GLUL.

Mi Zhang, Chanyuan Chen, Haifeng Zhang

|Sep 19, 2025
A Difluorinated Derivative of ARC-111 Suppresses Intrahepatic Cholangiocarcinoma Growth via Targeting Topoisomerase I.

Yin-Peng Bai, Mi Zhang, Jian-Hua Liu

|Feb 28, 2024
Targeting the IRE1α-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.

Tingting Zhang, Faming Zhao, Yi Zhang

|Feb 06, 2022
Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma.

Tingjie Wang, Ningxin Dang, Guangbo Tang

|May 13, 2020
Bmal1 integrates mitochondrial metabolism and macrophage activation.

Ryan K Alexander, Yae-Huei Liou, Nelson H Knudsen

Pageof 2

Frequent Collaborators

1 joint publications

Yin-Peng Bai

1 joint publications

Ying-Qian Liu

1 joint publications

Zhi-Jun Zhang

1 joint publications

Ying-Qian Liu